ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RPID vs HBIO // GROSS PROFIT MARGIN

Rapid Micro Biosystems Inc. (Class A) (NASDAQ) VS. Harvard Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: RPID 1 — HBIO 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RPID VS. HBIO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RPID HBIO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 57.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — 13.66% — TIE /fcf-yield <GO>
Operating Margin -60.00% -56.10% -3.90 HBIO /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 19.70% -8.10% +27.80 RPID /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 HBIO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 36.1 64.9 -28.80 HBIO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $39.6M $40.1M -$484.4K HBIO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RPID REV HBIO REV RPID GROSS % HBIO GROSS % RPID FCF HBIO FCF
FY 2025 $33.6M $86.5M — 57.7% -$31.9M $5.5M
FY 2024 $28.1M $94.1M — 58.2% -$45.5M -$1.2M
FY 2023 $22.5M $112.3M — — -$45.1M $14.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RPID // BETA —
HBIO // BETA —